ID

13503

Description

Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5)

Keywords

Versions (3)
  1. 11/5/15 11/5/15 -
  2. 1/2/16 1/2/16 -
  3. 2/11/16 2/11/16 -
Uploaded on

February 11, 2016

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Chemotherapy Treatment Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26

English

Chemotherapy Treatment Form

1 forms  
Cycle
Description

Cycle

Alias
UMLS CUI-1
C1302181
Form related to
Description

Form related to

Data type

integer

Alias
UMLS CUI [1,1]
C1276413
UMLS CUI [1,2]
C2348792
Patient Characteristics At Start Cylce
Description

Patient Characteristics At Start Cylce

Alias
UMLS CUI-1
C0683521
Weight
Description

Weight

Data type

float

Measurement units
  • kg
Alias
UMLS CUI [1]
C0005910
kg
Administration Of Treatment
Description

Administration Of Treatment

Alias
UMLS CUI-1
C0087111
Date start treatment
Description

Date start treatment

Data type

date

Measurement units
  • dd/mm/yyyy
Alias
UMLS CUI [1]
C0808070
dd/mm/yyyy
Drug
Description

Drug

Alias
UMLS CUI-1
C0013227
Drug
Description

Drug

Data type

integer

Alias
UMLS CUI [1]
C0013227
Total dose actually given
Description

Total dose actually given

Data type

float

Measurement units
  • mg
Alias
UMLS CUI [1]
C2986497
mg
Dosage
Description

Dosage

Data type

integer

Alias
UMLS CUI [1]
C0178602
Reason (if dosage >1)
Description

Reason

Data type

integer

Alias
UMLS CUI [1]
C1299575
Comments
Description

Research Comments

Data type

text

Alias
UMLS CUI [1]
C0947611
Back to the top of the page

Similar models

Chemotherapy Treatment Form

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Cycle
C1302181 (UMLS CUI-1)
Item
Form related to
integer
C1276413 (UMLS CUI [1,1])
C2348792 (UMLS CUI [1,2])
Form related to
Code List
Form related to
CL Item
induction cycle I  (1)
C1302181 (UMLS CUI-1)
CL Item
induction cycle II  (2)
C1302181 (UMLS CUI-1)
CL Item
post induction cycle III (3)
C1302181 (UMLS CUI-1)
Item Group
Patient Characteristics At Start Cylce
C0683521 (UMLS CUI-1)
Weight
Item
Weight
float
C0005910 (UMLS CUI [1])
Item Group
Administration Of Treatment
C0087111 (UMLS CUI-1)
Date start treatment
Item
Date start treatment
date
C0808070 (UMLS CUI [1])
Item Group
Drug
C0013227 (UMLS CUI-1)
Item
Drug
integer
C0013227 (UMLS CUI [1])
Drug
Code List
Drug
CL Item
Idarubicin (1)
C0020789 (UMLS CUI-1)
CL Item
Cytarabin (2)
C0010711 (UMLS CUI-1)
CL Item
Lenalidomide (3)
C1144149 (UMLS CUI-1)
CL Item
Daunorubicin (4)
C0011015 (UMLS CUI-1)
CL Item
Mitoxantrone (5)
C0026259 (UMLS CUI-1)
CL Item
Etoposide (6)
C0015133 (UMLS CUI-1)
Total dose actually given
Item
Total dose actually given
float
C2986497 (UMLS CUI [1])
Item
Dosage
integer
C0178602 (UMLS CUI [1])
Dosage
Code List
Dosage
CL Item
full dose according to schedule (1 )
CL Item
full dose given but start of treatment delayed (2 )
CL Item
daily dose reduced >10% (3 )
CL Item
daily dose reduced and start delayed (4 )
CL Item
not given (5 )
CL Item
interrupted during the cycle and resumed (6 )
CL Item
stopped early (7 )
CL Item
other (specify) (8 )
Item
Reason (if dosage >1)
integer
C1299575 (UMLS CUI [1])
Reason
Code List
Reason (if dosage >1)
CL Item
hematological toxicity (1)
C0279810 (UMLS CUI-1)
C0013221 (UMLS CUI-2)
CL Item
non-hematological toxicity (specify) (2)
C0013221 (UMLS CUI-1)
CL Item
other (specify) (8)
C0205394 (UMLS CUI-1)
Research Comments
Item
Comments
text
C0947611 (UMLS CUI [1])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial